Clinical trial
A Study to Examine APL-130277 in Patients With Parkinson's Disease
NCT02228590
Study timeline
Study start (actual)2014-08-31Date precision: day
Registry last updated2020-07-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson's Diseaseunresolved
Interventions
APL-130277DRUG
Sponsors & collaborators
Sumitomo Pharma America, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02228590 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.